Weiss Asset Management’s BioNTech BNTX Stock Holding History

Weiss Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-8,540	Closed	-$842K	–	613
2025 Q3	$842K	Buy	+8,540	New	+$913K	0.01%	377

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Weiss Asset Management's BNTX Position: Q4 2025 in Review

Weiss Asset Management sold out of BioNTech (BNTX) in Q4 2025, closing a stake of 8,540 shares — an estimated $842K sold.

Weiss Asset Management first reported a position in BNTX in Q3 2025 and held it in 1 quarter. The position peaked at $842K in Q3 2025. 284 funds tracked by Wall St. Rank hold BNTX as of Q4 2025.

Weiss Asset Management reported no remaining BioNTech position as of Q4 2025 after selling out during the quarter.
Weiss Asset Management sold 8,540 BioNTech shares in Q4 2025, an estimated $842K.
Weiss Asset Management first reported a position in BioNTech in Q3 2025 and held it in 1 quarter.
Weiss Asset Management's BioNTech position peaked at $842K in Q3 2025.
284 funds tracked by Wall St. Rank held BioNTech as of Q4 2025.

Based on Weiss Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.